I noticed several talks at the<U+00A0> JSM 2016 on enrichment designs. I was only very vaguely familiar with what this meant, so I did a quick Google search. I found this very nice non-technical overview.
Robert Temple (2014) Enrichment design studies should enhance signals of effectiveness. http://www.fda.gov/Drugs/NewsEvents/ucm295054.htm.
